Survival AnalysisSurvival RateCell SurvivalDisease-Free SurvivalTreatment OutcomeSurvivalRetrospective StudiesGraft SurvivalTime FactorsKaplan-Meier EstimatePrognosisFollow-Up StudiesNeoplasm StagingCombined Modality TherapyProportional Hazards ModelsAntineoplastic Combined Chemotherapy ProtocolsNeoplasm Recurrence, LocalRisk FactorsLung NeoplasmsMultivariate AnalysisLiver NeoplasmsProspective StudiesAge FactorsCohort StudiesAdenocarcinomaActuarial AnalysisLymphatic MetastasisRisk AssessmentBreast NeoplasmsChemotherapy, AdjuvantRegistriesAntineoplastic AgentsTumor Markers, BiologicalLiver TransplantationCisplatinApoptosisIncidenceCarcinoma, Squamous CellCarcinoma, HepatocellularNeoplasm MetastasisUnited StatesRecurrenceImmunohistochemistryDisease ProgressionPostoperative ComplicationsPredictive Value of TestsStomach NeoplasmsModels, StatisticalHepatectomyRadiotherapy, AdjuvantCarcinoma, Non-Small-Cell LungLife TablesCyclophosphamideDoxorubicinVincristineReoperationProbabilityFluorouracilRadiotherapy DosageBrain NeoplasmsNeoplasmsColorectal NeoplasmsKidney TransplantationDrug Administration SchedulePancreatic NeoplasmsInfant, NewbornNeoplasm InvasivenessCell Line, TumorModels, BiologicalEsophageal NeoplasmsRegression AnalysisRemission InductionCarcinomaGraft RejectionReproducibility of ResultsLymph Node ExcisionSignal TransductionTransplantation, HomologousMice, Inbred C57BLSex FactorsAnalysis of VarianceCause of DeathJapanSEER ProgramDisease Models, AnimalPrevalenceGastrectomyNeoadjuvant TherapyChi-Square DistributionPrednisoneAlgorithmsTissue DonorsEtoposideBone NeoplasmsBile Duct NeoplasmsPregnancyCell ProliferationDose-Response Relationship, DrugMutationChemoembolization, Therapeutic